Pros and cons of drugs to prevent breast cancerBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2891 (Published 08 May 2013) Cite this as: BMJ 2013;346:f2891
Pooled analyses of individual participant data from nine randomised trials have confirmed that selective oestrogen receptor (ER) modulators help prevent breast cancer in healthy women. Together, tamoxifen, raloxifene, arzoxifene, and lasofoxifene reduced the cumulative incidence of breast cancer by an estimated 38% relative to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial